Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AC
- Chemical substanceV03AC01Deferoxamine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 7 registrations
- Deferoxamine Mesylate for Injection2 G / VIAL · Powder For Solution · Pfizer Canada Ulc
- Deferoxamine Mesylate for Injection500 MG / VIAL · Powder For Solution · Pfizer Canada Ulc
- Desferal500 MG / VIAL · Powder For Solution · Mitem Pharma
- Deferoxamine Mesylate for Injection2 G / VIAL · Powder For Solution · Sandoz Canada Incorporated
Netherlands
CBG-MEB · 2 registrations
At a glance
- ATC code
- V03AC01
- ATC group
- Various
- Registers
- 7
- Historical lists
- 2
- Registrations
- 19
- With their own page
- 10
- Companies
- 15
All medicines with Deferoxamine
Human medicines from every register that match Deferoxamine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
19 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Deferoxamine Mesylate | United States | 2GM/VIAL, 500MG/VIAL | injectable | Marketed | DR Reddys |
| Deferoxamine Mesylate for Injection | Canada | 500 MG / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Deferoxamine Mesylate for Injection | Canada | 2 G / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Desferal | United States | 2GM/VIAL, 500MG/VIAL | injectable | Marketed | Mitem Pharma |
| Desferal | Canada | 500 MG / VIAL | Powder For Solution | Marketed | Mitem Pharma |
| DESFERIN 500 mg POLVO PARA SOLUCION INYECTABLE O PERFUSION | Spain | 0,5 g | polvo para solución inyectable y para perfusión | Marketed | Mitem Pharma |
| DBL DESFERRIOXAMINE MESYLATE FOR INJECTION BP 500 mg/vial | Singapore | 500 mg/vial | injection, powder, for solution | Authorised | Pfizer Private Limited |
| Desferal, poeder voor oplossing voor injectie of infusie 500 mg | Netherlands | Poeder voor oplossing voor injectie of infusie | Authorised | Mitem Pharma | |
| Desferal, poeder voor oplossing voor injectie of infusie 500 mg | Netherlands | Poeder voor oplossing voor injectie of infusie | Authorised | Eureco-Pharma B.V. | |
| DBL Desferrioxamine Mesylate for Inj BP | New Zealand | Inj 500 mg vial | Funded | ||
| Froxa | Saudi Arabia | Authorised | MS Pharma | ||
| Desferal 2 GM Vial | Saudi Arabia | Authorised | Novartis | ||
| Desferal Vial 500MG | Saudi Arabia | Authorised | Novartis Pharma AG | ||
| Deferoxamine Mesylate for Injection | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Sandoz Canada Incorporated |
| PMS-Deferoxamine | Canada | 500 MG / VIAL | Powder For Solution | Cancelled | Pharmascience INC |
| PMS-Deferoxamine | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Pharmascience INC |
| Desferal 2G | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Novartis Pharmaceuticals Canada INC |
| DESFERAL 500 mg | Romania | 500mg | pulb. pt. sol. inj./perf. | Status unknown | Novartis Pharma GMBH |
| Fauldesfer | Brazil | Cancelled | Disaq Farmacêutica Ltda |